Thursday 31 March 2022

Pet Insurance Market by Trupanion, Inc., Deutsche Familienversicherung AG (DFV), Petplan (Allianz), Animal Friends Insurance Services Limited

 The global Pet Insurance Market size is anticipated to reach USD 32.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 16.7% from 2022 to 2030. The key factors driving the market growth include the rising number of pets across the globe, high veterinary care costs, and the need to reduce financial risk. As per the Pet Food Manufacturers Association, about 59% of households had pets in the U.K. in 2021. Dogs were the most popular at about 33%, followed by cats at 27%. Other pets include rabbits, indoor birds, guinea pigs, tortoises and turtles, horses, and others.

The COVID-19 pandemic has impacted all industries, including the market. The surge in pet ownership during the pandemic, expenditure on pets, and increasing pet humanization further supported the adoption of pet insurance policies during 2020 and 2021. Concerns over rising veterinary care costs and fear of transmission of COVID-19 from pets to pet owners also increased the demand for reducing financial risks with a suitable pet insurance policy. Although OIE has confirmed that no animals can spread this virus. However, in the initial months of the pandemic, there was speculation that it may spread through birds. Overall, the pandemic positively impacted the market with increased awareness and adoption of insurance policies by pet parents.

Rapidly growing consumer awareness, underpenetrated market, and product acceptance have benefited the market. According to Petplan, in the U.S., the average cost of an unexpected visit to the veterinarian was around USD 800-1,500 in 2018. This burden could be eased with an insurance plan in place. Moreover, untapped opportunities in developed and developing economies are anticipated to provide lucrative growth to this market in the coming years. Furthermore, advancements in pet insurance, such as vet direct pay by Trupanion, are revolutionizing medical insurance for cats and dogs by eliminating the reimbursement model. Similarly, pet insurance in Europe is growing rapidly due to strict pet insurance regulations in countries such as Sweden.

In addition, strategic initiatives by market players are further expected to boost the market growth. For instance, in April 2020, Zoetis entered the pet insurance space by launching Pumpkin Insurance Services Inc.- a pet insurance agency across the U.S. The company offers competitive pet health insurance plans and preventive care plans to pet parents. In December 2019, MetLife, Inc. on the other hand, acquired PetFirst Healthcare, LLC - a companion animal health insurance administrator. This acquisition leveraged the company’s position as a leader in group benefits distribution channels in the U.S. by enabling MetLife to expand its offerings. Such initiatives are estimated to boost the market growth in the coming years. Insurance providers are also focused on increasing penetration by targeting the customer base of the sales channels. For instance, in February 2018, Healthy Paws collaborated with Roover.com to increase its market penetration.

Related Press Release@ Pet Insurance Market Report

Pet Insurance Market Report Highlights

  • The market was valued at USD 8.3 billion in 2021 and is expected to witness a CAGR of 16.7% during the forecast period
  • The dogs insurance segment held the highest share of the market in 2021. The high popularity of dogs as pets and increase in the number of dog pet owners across the globe are the key drivers for this segment
  • The direct sales segment dominated the market in 2021 while the others segment is estimated to grow the fastest over the forecast period
  • Market players are utilizing various sales channels to distribute their insurance products and increase their market share. Bancassurance, for instance, held a notable share of the market in 2021. This is due to growing collaborations between pet insurance companies and banks. For instance, in April 2018, CIMB Bank in Singapore was the first to launch pet insurance for a wide variety of pets
  • Based on coverage type, the accident and illness coverage segment accounted for the largest revenue share in 2021. The key drivers of the segment include high veterinary treatment and diagnostic cost, the rise of the companion animal population, and an increase in the awareness of pet insurance
  • The accident only segment held a substantial share of the market in 2021. The key drivers of the segment include increasing health issues in animals and high treatment cost
  • In 2021, Europe held the dominant share of the market. European countries were found to have a higher rate of pet insurance penetration along with the presence of key market players
  • North America held the second-largest revenue share as of 2021. The key drivers of the market are a rise in the companion animal population and an increase in awareness related to pet insurance
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com          

Wednesday 30 March 2022

Huntington’s Disease Treatment Market Worth $1.8 Billion By 2030

 The global Huntington’s Disease Treatment Market size is expected to reach USD 1.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.6% from 2022 to 2030. This growth is due to high R&D investments for new product development, research collaboration, and the high HD burden in western countries. Huntington's disease is a rare inherited neurodegenerative disease that affects several generations. It affects people between the ages of 30 and 50, impairing their capacity to work, care for their families, and, eventually, complete daily tasks.

The prevalence varies by more than ten-fold between geographical locations, which can be related to variations in case ascertainment and diagnostic criteria. The prevalence varies by more than ten-fold between geographical locations, which can be related to variations in case ascertainment and diagnostic criteria. As a result, the prevalence of enlarged repetitions in the general population may be greater than expected. The Asian population has consistently had a lower prevalence, while Europe, North America, and Australia have a higher prevalence.

The key players, such as Neurocrine Biosciences, Inc. and Azevan Pharmaceuticals, Inc., are focusing on research and development of symptomatic therapies for HD. Azevan Pharmaceuticals is developing SRX246 as an experimental drug to treat neuropsychiatric symptoms in Huntington's disease. SRX246 is a drug that works by blocking the vasopressin 1a (V1a) receptor in the brain. In the neurological system, V1a receptor is the major vasopressin receptor. SRX246 works by inhibiting the V1a receptor, restricting vasopressin from attaching to the receptor, and generating irritable and aggressive behavior, which is seen in Huntington's disease patients.

However, currently approved drugs provide symptomatic and palliative care and do not target the underlying cause of the disease. While medications can decrease the severity of symptoms, they are often associated with adverse effects such as somnolence, gait issues, dysphagia, and apathy, which can have serious impacts on a patient’s quality of life. Given the lack of a cure for the disease, it is critical to evaluate how Health-related Quality of Life (HRQOL) is affected in these patients. HD patients in early to middle stages of the disease need coordinated multidisciplinary healthcare services, including assessment of cognitive function and counseling.

Drug development for HD has faced significant obstacles as several therapies have failed to demonstrate efficacy or were associated with significant toxicity. Vaccinex Inc.'s phase II trial of Pepinemab failed to satisfy pre-specified co-primary endpoints in patients with early manifest and prodromal HD, in September 2020. The two co-primary endpoints—a family of two cognitive evaluations from the Huntington's disease Cognitive Assessment Battery and Clinical Global Impression of Change (CGIC)—did not attain statistical significance in the early manifestation population in the SIGNAL study.

Related Press Release@ Huntington’s Disease Treatment Market Report

Huntington’s Disease Treatment Market Report Highlights

  • The symptomatic treatment segment accounted for the largest revenue share in 2021 owing to the product availability and patent protection. Disease-modifying therapies is anticipated to be the fastest-growing segment over the forecast years due to the entry of SAGE-718, and Cellavita-HD
  • Companies are now focusing on the development of treatments that can be injected directly into the brain to directly inhibit the formation of mutant HTT protein, instead of targeting the mutant protein
  • Drugs with novel targets in early-phase development include Cellavita and Azidus Brazil’s Cellavita HD (stem cell therapy), Sangamo Therapeutics, Inc. mHTT ZFP (zinc finger protein), and UniQure’s AMT-130 (gene therapy)
  • North America held the highest revenue share in 2021 and is expected to dominate the market over the forecast period due to better reimbursement facilities and the high burden of HD in the U.S. and Canada
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com                                               

Endoscopes Market Worth $27.9 Billion By 2030 | CAGR 9.4%

The global Endoscopes Market size is expected to reach USD 27.9 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.4% from 2022 to 2030. Growing awareness levels about minimally invasive surgical procedures and the increasing prevalence of chronic disorders are the major factors accelerating the market growth. The benefits, such as less surgery-related blood loss, no muscle cutting, quicker recovery, offered by minimally invasive surgeries boost the adoption of endoscopic procedures over traditional/open invasive surgeries. In addition, advancement in endoscopic technology and rapid increase of its application to diagnose and treat various diseases are other key factors anticipated to propel the market growth over the forecast years. The flexible endoscopes product segment dominated the market in 2021.

This is attributed to the high demand for these devices on account of their unique features, such as the ability to reach viscera and cavities, better safety and efficiency, and improved ergonomic features. These devices are most commonly used in several endoscopic procedures, such as esophagogast roduodenoscopy (OGD), bronchoscopy, sigmoidoscopy, laryngoscopy, pharyngoscopy, nasopharyngoscopy, rhinoscopy, and colonoscopy procedures, which supports the product demand and segment growth.Based on application, in 2021, the Gastrointestinal (GI) endoscopy segment dominated the market owing to an increase in gastrointestinal disorders and a high preference for minimally invasive procedures. High volumes of GI endoscopic procedures and the availability of technologically advanced endoscopes to treat &diagnose functional gastrointestinal disorders are also driving the segment.

In 2021, the hospitals end-use segment dominated the market owing to favorable reimbursement policies and growing utilization of endoscopes in hospital systems. Furthermore, a larger number of endoscopic procedures is performed in hospital settings as compared to other healthcare systems, which boosts the segment growth.In addition, North America accounted for the highest revenue share in 2021 owing to its better healthcare infrastructure, high preference for minimally invasive surgical procedures among individuals, and quickadoption of advanced technologies. The increasing burden of functional gastrointestinal disorders and cancer is anticipated to further propel market growth in this region. For instance, as per the data reported by the National Cancer Institute, in 2020, over 1.8 million new cancer cases were estimated to be diagnosed in the U.S.

The overall decrease in the number of surgical procedures during COVID-19, in turn, impacted the growth of the market. Furthermore, to reduce the COVID-19 transmission risk, endoscopy centers have postponed and canceled the semi-urgent and elective cases, which affected the endoscopy procedure adoption in 2020.In addition, supply chain interruptions due to constant lockdown and shutdown imposed by the governments of top countries all over the globe also hampered the market growth in 2020. For instance, a study published in the Arab Journal of Gastroenterology in 2020stated that the endoscopy procedures volume decreased about 50% due to the COVID-19 pandemic in the majority of countries.

Related Press Release@ Endoscopes Market Report

Endoscopes Market Report Highlights

  • The flexible product segment held the largest revenue share in 2021 owing to its unique features, such as the ability to reach viscera & cavities, better safety & efficiency, and improved ergonomic features
  • GI application segment dominated the market in 2021 owing to an increase in gastrointestinal disorders and a high preference for minimally invasive procedures
  • In terms of end use, hospitals accounted for the highest revenue share in 2021 due to favorable reimbursement policies and the growing utilization of endoscopes in hospital systems
  • North America dominated the market in 2021 owing to various factors including the increasing burden of functional gastrointestinal disorders, improved healthcare infrastructure, and the growing preference for minimally invasive surgeries to curb healthcare spending

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com                                              

 

   

Tuesday 29 March 2022

Skin Boosters Market Size Worth $2.1 Billion By 2030

 The global Skin Boosters Market size is anticipated to reach USD 2.1 billion by 2030, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 9.3% from 2022 to 2030. Skin Boosters is a procedure wherein microinjections of biocompatible compounds like hyaluronic acid, vitamins, minerals, anti-oxidants, etc. that are naturally produced by the body are injected into the epidermis or mesoderm. Skin boosters simply help aid in the hydration process, which is fundamental for a youthful glow.

Unlike dermal fillers, skin boosters are not for wrinkle reduction or augmentation, their role is to primarily hydrate the skin and promote the formation of new collagen and elastin to give the skin a firmer appearance. Factors like rising technological advancement in aesthetics, rising disposable income, increasing aesthetic consciousness, and the increasing geriatric population in the search for a natural glow are propelling the market growth. According to Galderma, over five million treatments of Restylane Skinboosters have been performed to date.

The demand for skin boosters is expected to propel significantly due to the fact that it provides a natural glow without distorting facial features or making them appear out of proportion. Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth.

In the light of COVID-19, the market was hampered as the footfall of patient appointments for surgical treatments was temporarily suspended. However, since the government in many countries has allowed resuming elective aesthetic procedures the demand for skin boosters has been on the rise. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to propel market growth.

Related Press Release@ Skin Boosters Market Report

Skin Boosters Market Report Highlights

  • By type, the mesotherapy procedure held the largest revenue share in 2021 as the procedure has minimal downtime and the booster can be inserted deeper for effective skin rejuvenation
  • The female segment held the largest revenue share in 2021 as women are more willing to undergo cosmetic treatment
  • The MedSpa segment held the largest revenue share in 2021. This is due to the fact that MedSpa provides aesthetic treatments under the supervision of a licensed medical practitioner
  • North America dominated the market and accounted for the highest revenue share in 2021 as the region has a high awareness of such procedures and there is high availability of aesthetic professionals
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com                                               

Brazil Sports Nutrition Market by Abbott, PepsiCo, The Coca Cola Company, MusclePharm, Glanbia

 


The Brazil Sports Nutrition Market size is expected to reach USD 1.56 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.8% from 2022 to 2030. The expanding consumer base for sports nutrition products from athletes and bodybuilders to active lifestyle users is a major parameter driving the market in Brazil. Consumers are increasingly adopting a healthy lifestyle to enhance their quality of life.

Additionally, the COVID-19 pandemic has increased awareness regarding health and wellness. This, in turn, has increased the adoption of various supplements including sports nutrition products. Moreover, rapidly growing instances of obesity are increasing the adoption of a healthy lifestyle. According to a report COVID-19 and Obesity: The 2021 Atlas, the prevalence of obesity in men is estimated to reach 25.2% by 2025 in Brazil. Obesity results in various health complications such as diabetes and hypertension.

Growing awareness regarding obesity and its complications and various initiatives undertaken by public and private authorities to combat obesity are estimated to increase participation in sports and fitness activities. For instance, the National Food and Nutrition Security Plan (Plansan) was introduced in Brazil from 2016 to 2019 to control the growth of obesity in Brazil. Gym-goers and fitness enthusiasts consume sports nutrition products for various benefits such as delaying fatigue, improving strength, and reducing the risk of heat cramps. This, in turn, is estimated to fuel the market growth potential.

Manufacturers operating in the Brazil sports nutrition space are offering innovative products to their consumers to increase product adoption and penetration. For instance, ProbiĂłtica Laboratories Ltda offers Carb Up Gum in lemon and cherry flavor. The company also offers Carb Up Wafel, a carbohydrate-containing waffle in Brazil. Such innovative products are increasing the adoption of sports nutrition products, especially among active lifestyle users. Companies are investing significantly in providing innovative products with new flavors to gain a wider audience for their products.

Additionally, an increasing number of manufacturers are launching plant-based products to cater to the growing consumer demand. Plant-based proteins such as soy protein, rice protein, and pea protein are rapidly gaining traction in the market. Various sports nutrition products with applications such as immunity enhancement, cognitive enhancement, endurance improvement, and muscle growth are easily available in the market through a wide distribution network. Thus, various initiatives by key stakeholders are estimated to drive the market during the forecast period.

Related Press Release@ Brazil Sports Nutrition Market Report

Brazil Sports Nutrition Market Report Highlights

  • Sports supplements emerged as the leading product type segment in 2021 with a revenue share of over 40.0%. The growth can be attributed to the increasing popularity of plant-based protein supplements such as soy protein, rice protein, and pea protein supplements
  • The post-workout application segment accounted for the largest revenue share in 2021 owing to the high consumption of post-workout supplements by athletes and gym-goers
  • In terms of formulation, powder accounted for the largest revenue share in 2021. The gummies segment is projected to expand at the fastest CAGR during the forecast period.
  • The adult consumer group segment accounted for the largest revenue share in 2021 and it is expected to be the fastest-growing segment during the forecast period
  • Based on distribution channel, brick and mortar accounted for the largest revenue share in 2021. The e-commerce segment is projected to expand at a significant CAGR during the forecast period
  • By end-use, the recovery segment accounted for the largest revenue share of over 20.0% in 2021. The endurance segment is projected to expand at the fastest CAGR during the forecast period

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Disposable Endoscopes Market Size Worth $7.3 Billion By 2030

 

The global Disposable Endoscopes Market size is expected to reach USD 7.3 billion by 2030, registering a CAGR of 17.0% over the forecast period, according to a new report by Grand View Research, Inc. The growing demand for single-use endoscopes to eliminate the risk associated with reusable endoscopic devices is one of the major factors driving the market growth. In addition, disinfecting and cleaning of reusable endoscopes and their accessories are the most critical task for physicians, and the risk of infection associated with the endoscope accessories cannot be underestimated. For instance, according to the survey on the contamination of patient-ready endoscopes from three hospitals, published in the American Journal of Infection Control in 2018, told that microbial growth was found in 71% of the reusable endoscopes.

In addition, reusable endoscopes and their accessories are subject to the risk of leakage and clogging due to deterioration over time, which, in turn, drives the demand for disposable endoscopes owing to their low cross-contamination risk. By application, the bronchoscopy segment accounted for the highest market value share in 2021. Increasing adoption of single-use bronchoscopes in several therapeutic procedures including tumor debulking and foreign body removal to treat the disease conditions, such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, is expected to drive the segment. Furthermore, patient infections can occur exogenously mainly due to contaminated equipment, but single-use bronchoscopes reduce the risk of infection for both physician and the patient, which will boost its demand.

The hospital end-user segment dominated the market in 2021 owing to the presence of a large number of hospitals performing endoscopic procedures. However, the clinics' segment is expected to grow at the fastest CAGR over the forecast years due to the increasing preference for and high adoption of cost-effective disposable endoscopes over reusable ones to perform endoscopic procedures in the clinics. North America was the dominant regional market in 2021. The rising adoption of advanced technologies, the presence of advanced infrastructure, and increasing awareness regarding minimally invasive surgeries are some of the prominent factors propelling the market growth in the region.

In addition, the rising prevalence of conditions, such as gastrointestinal disorders and cancer, coupled with, the growing geriatric population is the other factor supporting regional growth. The reduction of overall surgical procedures during the COVID-19 pandemic has partially affected the overall endoscope industry growth in 2020. However, the use of single-use endoscopes can reduce the viral transmission to the healthcare personnel conducting the procedures, which is expected to boost its adoption over the forecast years. Therefore, the market has seen growth during the pandemic.

Related Press Release@ Disposable Endoscopes Market Report

Disposable Endoscopes Market Report Highlights

  • The bronchoscopy application segment dominated the market in 2021 owing to the high adoption of single-use bronchoscopes in several therapeutic procedures such as COPD and asthma
  • The hospital end-user segment dominated the market with a revenue share of 47.5% in 2021, owing to the increasing adoption of disposable endoscopes in hospitals
  • North America dominated the market and accounted for the largest revenue share of 41.7% in 2021, owing to growing awareness and increasing adoption of disposable endoscopes in healthcare institutions in the region
  • New product launches coupled with an increasing number of approvals by regulatory authorities are also expected to boost the market growth over the forecast years
  • For instance, Ambu, a medical device manufacturer, in July 2020, received U.S. FDA 510(k) clearance for its disposable duodenoscope
  • The device includes single-use endoscope “aScope” and reusable processor unit “aBox” used to treat and diagnose several conditions like pancreatitis, gallstones, tumors, or cancer in the pancreas and bile duct

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Liposuction Surgery Devices Market - Future Trends, Revenue Growth & Leading Players, Forecast To 2030

 The global Liposuction Surgery Devices Market size is expected to reach USD 7.5 billion by 2030 at a CAGR of 12.5%, according to a new report by Grand View Research, Inc. Increased awareness regarding new cosmetic treatments in the developed economies, such as North America is one of the major driving factors of the liposuction surgery devices. In addition, the integration of modern technology and the adoption of technologically advanced surgical devices is fueling market growth.

The growing demand for cosmetic surgeries across the globe is another driving factor of this market. Lipoplasty is one of the common cosmetic surgeries witnessed in the United States. Annually, more than 3,00,000 liposuction surgeries are operated with an approximate cost of $2000-3500. The high disposable income of consumers is another driving factor for the growth of liposuction surgery in North America. These factors are expected to propel industry growth.

Suction-assisted lipectomy, power-assisted, ultrasound-assisted, laser-assisted, and RF-assisted are some of the current technologies used in surgeries. Different technologies are used based on the patient’s body characteristics and cosmetic surgeon’s preference. The right use of technology will bring a better outcome to lipoplasty surgery.

In addition, the rising obesity cases are increasing the demand for liposuction surgery. However, minor complications, such as numbness, swelling, bad bruising, and more associated with targeted surgery is hampering the market growth. Nonetheless, increasing research and development in the domain and the launch of new technologies are expected to overcome these drawbacks.

Related Press Release@ Liposuction Surgery Devices Market Report

Liposuction Surgery Devices Market Report Highlights

  • The standalone segment accounted held a dominant share of the liposuction surgery devices market in 2018 in terms of revenue. Easy usage, convenience, and growing innovations in the devices are expected to propel the segment growth in the coming years
  • A growing number of qualified & trained cosmetic surgeons and practitioners are encouraging patients to opt for such cosmetic surgeries.
  • The laser-assisted liposuction (LAL) segment held a significant share of the market due to the increasing adoption owing to its benefits, such as a quick and effective way of removing body fat.
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Friday 25 March 2022

Wound Care Market by Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson)

The global Wound Care Market size is anticipated to reach USD 29.57 billion by 2030, registering a CAGR of 4.12% during the forecast period, according to a new report by Grand View Research, Inc. Increasing number of surgical cases, rapidly aging population, as well as rising number of diabetic patients, are among the major factors driving the market growth. For instance, according to Ageing Asia, in 2019, more than 139 million people i.e., about 10% of the total population, in India were over the age of 60 years. The number is expected to increase to 19.5% by 2050. Elder people are more susceptible to wounds, and thus, an increasing number of geriatric population is anticipated to propel the market growth. Obesity is a major health concern that leads to several other diseases or complications, such as diabetes and Cardiovascular Diseases (CVDs).

As per the WHO, in 2016, over 1.9 billion adults were overweight, out of which, around 650 million people were obese and around 2.8 million people die each year due to obesity. Such instances are expected to increase the demand for bariatric procedures and other related surgeries, thereby, propelling the market growth. Furthermore, with the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions, the market is expected to witness rapid growth in the coming years. Many elective surgeries, which were postponed are expected to take place. In addition, many leading manufacturers are introducing new products, which may help them capitalize on the increasing demand for wound care products during the forecast period.

Related Press Release@ Wound Care Market Report

Wound Care Market Report Highlights

  • The advanced wound dressing product segment dominated the market accounting for the maximum revenue share in 2021, owing to a rise in the number of diabetic pressure ulcer patients
  • Based on active wound care, the biomaterials segment dominated the market and is expected to expand a considerable CAGR from 2022 to 2030
  • This growth can be attributed to rapid technological advancements and a rise in the number of burn cases across the globe
  • Based on application, the chronic wound segment is likely to witness the fastest CAGR during the forecast period owing to increasing cases of traumatic injuries
  • The hospital end-use segment dominated the market in 2021 owing to the high volume of surgical site infections among patients in hospitals
  • On the other hand, the home healthcare segment is anticipated to witness the fastest CAGR during the forecast period
  • North America was the dominant regional market in 2021 due to the increased volume of surgical procedures and technological advancements

Patient Engagement Solutions Market by Cerner Corporation (Oracle), NextGen Healthcare, Inc., Epic Systems Corporation

 The global Patient Engagement Solutions Market size is expected to reach USD 70.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 17.4% from 2022 to 2030. The key factors fueling the market growth include rising digitalization across healthcare, increasing prevalence of chronic conditions, and technological advancements. The COVID-19 pandemic boosted digitalization across healthcare. This, in turn, has fueled the awareness and adoption of patient engagement solutions, thus propelling the market growth.

As healthcare providers were battling with the constant upsurge in cases, patients were looking to digital technologies for care delivery and monitoring. This contributed to the market growth. Various key companies released multiple COVID-19-related features as part of their patient engagement lineup to enhance their offerings. In December 2020, athenahealth released new features to its athenaOne platform-such as scheduling, workflow, documentation, and reporting capabilities-to enable immediate administration of COVID-19 vaccines as and when they become available.

The necessity of social distancing resulted in the demand for remote patient monitoring solutions, along with the prerequisite for the precise and timely exchange of patient wellbeing records. The pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants had come up with COVID-19-related features into their existing patient engagement solutions. For instance, in June 2020, Orion Health partnered with a network of more than 350 healthcare facilities called Keystone Health Information Exchange to enable real-time automated COVID-19 reporting for improved public health data collection across Pennsylvania and New Jersey.

As per a survey by Twilio, a provider of cloud communications and customer engagement, 68% of respondents reported accelerated digitalization in their organizations due to COVID-19. Companies reported easing of barriers at organization levels such as getting executive approvals, lack of clear strategy, and reluctance to replace legacy software. In fact, according to the Chief Product Officer at Mount Sinai Health System, their newly developed text‑to‑chat platform witnessed a 10x surge in volume due to the pandemic. The growing number of smartphone users around the globe expedited the adoption of digital health technologies across the sector both from providers and consumers, which, in turn, has augmented the dependability of patients on mHealth apps.

Moreover, in March 2019, the American Medical Association entered into a collaboration with Patient Point with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using PatientPoint technology, approximately 6,500 practicing doctors across the U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to fuel the market growth over the forecast period. 

Related Press Release@ Patient Engagement Solutions Market Report

Patient Engagement Solutions Market Report Highlights

  • The web and cloud-based segment emerged as the largest delivery type segment in 2021 as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and accessed remotely
  • By component, the software and hardware segment dominated the market in 2021 owing to the continuous development in patient engagement solutions, along with the increasing applications in health and wellness, patient education, and chronic disease management
  • The rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for patient engagement solutions in the coming years
  • The communication functionality segment dominated the market in 2021 as it forms the core of any patient engagement solution. Market players are continuously releasing upgrades and new features to enhance offerings. For instance, in November 2020, Cerner partnered with WELL Health Inc. to boost the communication capabilities of its patient portal- HealtheLife
  • North America dominated the global market in 2021 owing to the increased adoption of m-health and electronic health records (EHRs) and growing investments in patient engagement software by major companies
  • Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players 
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com                                               

Thursday 24 March 2022

Electronic Health Records Market by Cerner Corporation (Oracle), GE Healthcare, Allscripts Healthcare, LLC, McKesson Corporation, Epic Systems Corporation

The global Electronic Health Records Market size is expected to reach USD 38.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.0% from 2022 to 2030. The web-based electronic health records (EHRs) are anticipated to show the largest growth during the forecast period. These EHRs are convenient for use in pharmacies, small-scaled laboratories, and clinics, as they require limited hardware infrastructure, which reduces the cost of installation. 

EHR vendors and organizations have initiated to help in curbing the pandemic by making telehealth a mainstream alternative, enhancing data access through EHRs, and collaborating to develop COVID-19 dashboards in detail. The introduction of EHRs for medical coding and billing has eased the process as data entering into computerized systems is more convenient than paper-based methods. EHRs also minimize the risk of errors in patient data as well as financial details. As per the University of Michigan, the cost of outpatient care was reduced by 3% upon shifting to EHRs from paper-based records. This reduction resulted in USD 5.14 savings per patient per month. 

Additionally, M&A activities by market players are also boosting the market growth. For instance, in February 2021, Evident, LLC, a subsidiary of CPSI announced that Texas-based Curahealth Hospitals and Cobalt Rehabilitation, have selected the Evident EHR along with collection services TruBridge, for three new rehabilitation facilities located in Denver, Colorado; West Houston, Texas; and San Antonio, Texas. Key players in the EHR market are investing in the launch of new products and collaborations for sustaining in the market. For instance, in August 2020, Cerner Corporation collaborated with Amazon to integrate its EHR solutions with the latter’s wearables such as Amazon Halo. This would provide greater interoperability to its customers and strengthen its service portfolio. 

Related Press Release@ Electronic Health Records Market Report

Electronic Health Records Market Report Highlights 

  • The web-based EHR segment dominated the overall revenues share as of 2021 and is projected to witness a CAGR of over 4.6% from 2022 to 2030. A high adoption rate by physicians is expected to boost the market growth
  • The ambulatory use segment which includes physician clinics, laboratories, and pharmacies is expected to exhibit the fastest growth over the forecast period owing to the increasing number of ambulatory care centers globally
  • The acute care segment held a considerable market share of about 46.8% in the market due to government initiatives for the adoption of EHRs
  • North America held a major market share as of 2021, due to the presence of well-established healthcare infrastructure as well as favorable government initiatives regarding population health management
  • The U.S. is dominating the market in North America due to the presence of established players in the country
  • The industry participants are focusing on product launch, partnerships, collaborations, mergers, and acquisitions to sustain the competition
  • In Asia Pacific, the market is anticipated to witness lucrative growth of around 6.9% owing to the developing healthcare infrastructure in Asian countries, such as Indonesia, China, and India 

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Ocular Implants Market by Alcon, Inc., Bausch & Lomb, Inc., Carl Zeiss AG, Johnson & Johnson

 The global Ocular Implants Market size is expected to reach USD 22.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.8% from 2022 to 2030. Increasing focus on the development of technologically advanced products is expected to drive the market. Additionally, the growing incidence of eye disorders such as glaucoma, cataract, and age-related macular degeneration is predicted to propel the demand for ocular implants. According to the World Glaucoma Association, an estimated 79.6 million individuals were anticipated to have glaucoma in 2020.

Due to the imposition of multiple lockdown restrictions, travel restrictions, and complete lockdowns in many countries, the economies worldwide have observed a major loss moving it into a state of recession. The COVID-19 impact was also strongly felt across the healthcare systems. While certain markets witnessed a major rise in demand due to the need for ocular implants in diagnoses and the treatment of COVID-19, certain other products observed a sharp fall in sales, especially during the peak of the pandemic. The market belonged to the latter and witnessed a negative impact due to the outbreak of COVID-19. The cancellation and postponement of elective surgeries in order to avoid the transmission of the virus to the staff and patients led to a fall in the sales of ocular implants in 2020.

However, the introduction of vaccines and specific strategies based on earlier experience to curtail the similar impact of the third or fourth wave in most countries is helping the market to regain its growth. Additionally, the outbreak of COVID-19 has created a higher preference among patients to visit specialty eye institutes rather than hospitals in order to avoid crowded places that pose a higher threat of contracting the virus, thereby increasing the demand for specialty clinics. Moreover, the new dynamics involved in the occupation and education system have increased the overall screen-time of individuals, which is expected to contribute to the rising incidence of eye diseases. This, in turn, is expected to enhance the market growth during the forecast period.

Related Press Release@ Ocular Implants Market Report

Ocular Implants Market Report Highlights

  • The glaucoma implants product segment dominated the market in 2021 owing to the growing incidence of glaucoma globally
  • The glaucoma surgery application held the largest revenue share in 2021 and this trend is expected to continue during the forecast period
  • By end use, the hospitals segment dominated the market with a revenue share of more than 40.0% in 2021 due to the increasing number of hospital admissions across the globe
  • The specialty eye institutes end-use segment is expected to witness significant growth during the forecast period owing to the rising need for eye care services in remote areas
  • Asia Pacific is anticipated to register the highest CAGR of 7.1% over the forecast period due to the increase in the diabetic population in this region, which is highly susceptible to developing eye disorders
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com                                               

Digital Pathology Market Size To Reach $1.73 Billion By 2030

The global  Digital Pathology Market  size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, acco...